ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 258625 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 258625; 2) Community: the network communities that were significantly associated with the response to NSC 258625; 3) Molecule: the relationships between components within communities and NSC 258625; 4) MDR: the compounds that were significantly associated with the NSC 258625.

NSC Compound Enrichment Correlation
NSC 83066 8-Quinolinol, 5-(chloromethyl)-, hydrochloride 0.0174989034030623 0.29154673
NSC 85235 10.alpha.H-Ambrosa-2,11(13)-dien-12-oic acid, 6.beta.-hydroxy-4-oxo-, .gamma.-lactone (8CI) 0.0174989034030623 0.61579491
NSC 87500 Solacongestidine 0.0174989034030623 0.12487521
NSC 298223 Antibiotic CC 1065 (9CI) 0.0201565205286441 -0.029906298
NSC 526333 2,5-Cyclohexadiene-.delta.(1,.alpha.)-acetonitrile, 4-oxo-.alpha.-phenyl-, O-acetyloxime 0.0201565205286441 0.31167263
NSC 617076 Free base of NSC 610966 0.0201565205286441 0.080626803
NSC 627890 Null 0.0201565205286441 0.085881653
NSC 645016 Null 0.0201565205286441 0.130634
NSC 677005 Null 0.0201565205286441 0.073141648
NSC 677274 Uracil, 3-methyl-6-(phenylhydrazino)- 0.0201565205286441 0.47319265
Total:91  Current:38    [First] [Prev] [Next] [Last]